CORV share price trailing 3-Y Beta is 0.33, making a possible lower RoR yet also presenting less risk. Profit to share is at -$0.31 over last 12 months. Share prices decreased -8.43 (%) (YTD) for a rise of 47.1 (%) over the last twelve months. Stock prices are -56.49 (%) from year high of $5.24 and 74.05 with the 52 Week lowest stock price at $1.31. Overall the stocks consensus estimates are 2 – out of 5, stock experts rate these shares a buy.
Correvio Pharma Corp. (CORV) could see increases of 204.82 (%) within the next year to $13.92price as 12-month high target. For a 510.53 (%) increase compared to the stocks current price. The 12-month median targeted valuation forecasted price by stock experts is $9.49, possible return at 316.23 (%) as share prices closed at $2.28 on Wednesday, January 16. The bottom estimated targeted valuation for shares are $3.59 an increase upwards of 57.46 (%) than CORV’s stock price today.
Stocks for Correvio Pharma Corp. decreased due to 3 earnings reactions and increasing 0.04 (%) on earnings reports.
The Company’s stock prices are at $2.15. With support at $2.02. Up to now CORV shares trade higher than this price, investors are OK for now. RSI went to 38.49 which seems OK. Yet if stock prices go to $2.02 more sell-offs are forecasted. However if shares go to $2.36 then we could see trading at a $2.45 price.
It has a 3.06 P/S ratio. Price-to-Sales ratio at 4. 68.9 (%) GPM for Correvio Pharma Corp. with OPM currently at -38.8 (%). NPM is -69.1 (%).